Pharmaceutical Policy in Countries with Developing Healthcare Systems
A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common
- PDF / 6,864,897 Bytes
- 425 Pages / 439.42 x 683.15 pts Page_size
- 33 Downloads / 265 Views
Pharmaceutical Policy in Countries with Developing Healthcare Systems
Pharmaceutical Policy in Countries with Developing Healthcare Systems
Zaheer-Ud-Din Babar Editor
Pharmaceutical Policy in Countries with Developing Healthcare Systems
Editor Zaheer-Ud-Din Babar Department of Pharmacy School of Applied Sciences University of Huddersfield Huddersfield United Kingdom
ISBN 978-3-319-51672-1 ISBN 978-3-319-51673-8 (eBook) DOI 10.1007/978-3-319-51673-8 Library of Congress Control Number: 2017935022 © Springer International Publishing AG 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Adis imprint is published by Springer Nature The registered company is Springer International Publishing AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
To my grandfather
Foreword
Pharmaceutical policy refers to the implementation of legislation, regulation, procedures, and principles to attain certain objectives. These objectives are usually spelled out in the national medicines policy and, at a minimum, should encompass sustainable and equitable access to affordable quality medicines for the population. The extent of this commitment –whether it includes only essential medicines or also more specialised medicines for example – will vary based on the country’s resources and the country context (e.g. industrial policy considerations). Achieving equitable access to affordable quality medicines through sound pharmaceutical policies is a challenge for countries at all levels of health system development. The challenge is even greater for countries working towards universal health coverage, where some parts of the population still rely heavily on out-ofpocket payments to access their medicines (e.g. Brazil, Ecuador, China, East African Community countries, Pakistan, Philippines, Russia, South Africa, and V
Data Loading...
